Cargando…
In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology
Injectable bone substitutes (IBS) are increasingly being used in the fields of orthopedics and maxillofacial/oral surgery. The rheological properties of IBS allow for proper and less invasive filling of bony defects. Vaterite is the most unstable crystalline polymorph of calcium carbonate and is kno...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835873/ https://www.ncbi.nlm.nih.gov/pubmed/35163120 http://dx.doi.org/10.3390/ijms23031196 |
_version_ | 1784649539376906240 |
---|---|
author | Unger, Ronald E. Stojanovic, Sanja Besch, Laura Alkildani, Said Schröder, Romina Jung, Ole Bogram, Caroline Görke, Oliver Najman, Stevo Tremel, Wolfgang Barbeck, Mike |
author_facet | Unger, Ronald E. Stojanovic, Sanja Besch, Laura Alkildani, Said Schröder, Romina Jung, Ole Bogram, Caroline Görke, Oliver Najman, Stevo Tremel, Wolfgang Barbeck, Mike |
author_sort | Unger, Ronald E. |
collection | PubMed |
description | Injectable bone substitutes (IBS) are increasingly being used in the fields of orthopedics and maxillofacial/oral surgery. The rheological properties of IBS allow for proper and less invasive filling of bony defects. Vaterite is the most unstable crystalline polymorph of calcium carbonate and is known to be able to transform into hydroxyapatite upon contact with an organic fluid (e.g., interstitial body fluid). Two different concentrations of hydrogels based on poly(ethylene glycol)-acetal-dimethacrylat (PEG-a-DMA), i.e., 8% (w/v) (VH-A) or 10% (w/v) (VH-B), were combined with vaterite nanoparticles and implanted in subcutaneous pockets of BALB/c mice for 15 and 30 days. Explants were prepared for histochemical staining and immunohistochemical detection methods to determine macrophage polarization, and energy-dispersive X-ray analysis (EDX) to analyze elemental composition was used for the analysis. The histopathological analysis revealed a comparable moderate tissue reaction to the hydrogels mainly involving macrophages. Moreover, the hydrogels underwent a slow cellular infiltration, revealing a different degradation behavior compared to other IBS. The immunohistochemical detection showed that M1 macrophages were mainly found at the material surfaces being involved in the cell-mediated degradation and tissue integration, while M2 macrophages were predominantly found within the reactive connective tissue. Furthermore, the histomorphometrical analysis revealed balanced numbers of pro- and anti-inflammatory macrophages, demonstrating that both hydrogels are favorable materials for bone tissue regeneration. Finally, the EDX analysis showed a stepwise transformation of the vaterite particle into hydroxyapatite. Overall, the results of the present study demonstrate that hydrogels including nano-vaterite particles are biocompatible and suitable for bone tissue regeneration applications. |
format | Online Article Text |
id | pubmed-8835873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88358732022-02-12 In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology Unger, Ronald E. Stojanovic, Sanja Besch, Laura Alkildani, Said Schröder, Romina Jung, Ole Bogram, Caroline Görke, Oliver Najman, Stevo Tremel, Wolfgang Barbeck, Mike Int J Mol Sci Article Injectable bone substitutes (IBS) are increasingly being used in the fields of orthopedics and maxillofacial/oral surgery. The rheological properties of IBS allow for proper and less invasive filling of bony defects. Vaterite is the most unstable crystalline polymorph of calcium carbonate and is known to be able to transform into hydroxyapatite upon contact with an organic fluid (e.g., interstitial body fluid). Two different concentrations of hydrogels based on poly(ethylene glycol)-acetal-dimethacrylat (PEG-a-DMA), i.e., 8% (w/v) (VH-A) or 10% (w/v) (VH-B), were combined with vaterite nanoparticles and implanted in subcutaneous pockets of BALB/c mice for 15 and 30 days. Explants were prepared for histochemical staining and immunohistochemical detection methods to determine macrophage polarization, and energy-dispersive X-ray analysis (EDX) to analyze elemental composition was used for the analysis. The histopathological analysis revealed a comparable moderate tissue reaction to the hydrogels mainly involving macrophages. Moreover, the hydrogels underwent a slow cellular infiltration, revealing a different degradation behavior compared to other IBS. The immunohistochemical detection showed that M1 macrophages were mainly found at the material surfaces being involved in the cell-mediated degradation and tissue integration, while M2 macrophages were predominantly found within the reactive connective tissue. Furthermore, the histomorphometrical analysis revealed balanced numbers of pro- and anti-inflammatory macrophages, demonstrating that both hydrogels are favorable materials for bone tissue regeneration. Finally, the EDX analysis showed a stepwise transformation of the vaterite particle into hydroxyapatite. Overall, the results of the present study demonstrate that hydrogels including nano-vaterite particles are biocompatible and suitable for bone tissue regeneration applications. MDPI 2022-01-21 /pmc/articles/PMC8835873/ /pubmed/35163120 http://dx.doi.org/10.3390/ijms23031196 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Unger, Ronald E. Stojanovic, Sanja Besch, Laura Alkildani, Said Schröder, Romina Jung, Ole Bogram, Caroline Görke, Oliver Najman, Stevo Tremel, Wolfgang Barbeck, Mike In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology |
title | In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology |
title_full | In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology |
title_fullStr | In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology |
title_full_unstemmed | In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology |
title_short | In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology |
title_sort | in vivo biocompatibility investigation of an injectable calcium carbonate (vaterite) as a bone substitute including compositional analysis via sem-edx technology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835873/ https://www.ncbi.nlm.nih.gov/pubmed/35163120 http://dx.doi.org/10.3390/ijms23031196 |
work_keys_str_mv | AT ungerronalde invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT stojanovicsanja invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT beschlaura invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT alkildanisaid invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT schroderromina invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT jungole invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT bogramcaroline invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT gorkeoliver invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT najmanstevo invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT tremelwolfgang invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology AT barbeckmike invivobiocompatibilityinvestigationofaninjectablecalciumcarbonatevateriteasabonesubstituteincludingcompositionalanalysisviasemedxtechnology |